Tech Transfer Roundup: Universities And Biotechs Continue To Look For Ways To Combat COVID-19

AlloVir/Baylor, Soligenix/Hawaii and CEL-SCI/Georgia ink coronavirus collaborations, but deal-making continues in other areas as well, including Asklepios/UNC teaming on a gene therapy for Angelman syndrome and DeMelle licensing a targeted pancreatic cancer drug from Moffitt, among others.

Tech Transfer regular column feature image

Below is Scrip’s regular roundup, including information from Strategic Transactions, of recent technology transfer agreements and collaborations between companies and academic or other research institutions.

More from Deals

More from Business